BHP and mining equipment company Epiroc Australia have resolved a lawsuit by Rio Tinto subsidiary Technological Resources over a patent for an autonomous drilling system.
Element Zero has denied claims that three former Fortescue employees, including one executive, misused confidential information and developed a green iron process on the company dime.
Bayer has filed a High Court challenge to a decision that invalidated its patents for blockbuster blood thinner Xarelto, saying it would adversely affect drug research and development.
AI tech company Paige can’t patent a tool to provide quality control for analysis of pathology images, with IP Australia finding the invention is merely an âadministrative schemeâ to automate the role of human pathologists.Â
Vittoria has defeated claims in an intellectual property battle that it infringed on rival Koninklijke Douwe Egbert’s trade mark for the design of its Moccona instant coffee jar.
Green iron start-up Element Zero is continuing its fight over search orders won by rival Fortescue that it claimed were a massive over-reach.
Coles has defeated a trade mark challenge to its Perform brand of sports nutrition products by a sports equipment company.
Bayer has lost its battle to protect top-selling blood thinner Xarelto from generic competition, with the Full Court finding two patents for the drug are invalid.
Fortescue has defeated a bid by its former CFOâs green iron start-up to set aside search orders that were said to have been secured âoff the back of egregious material non-disclosureâ. Â
Samsung Bioepis can’t get indemnity costs from Janssen Biotech after it surrendered patents for Crohnâs disease drug Stelara and filed a fresh case based on new patents for the drug.Â